Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q4 2023 Earnings

7MarConfirmed

Q4 2023

-2.7

-2.1

-1.5

-0.9

Details

Expected EPS

-0.9

Actual EPS

-2.7

Surprise EPS

-1.8

Surprise Percent

+200%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -2.7 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.